THEME : LIVER TRANSPLANT BEYOND BORDERS
Day 1 - 17 November, Friday
Day 2 - 18 November, Saturday
Day 3 - 19 November, Sunday
HALL A |
Topics |
Robotic donor hepatectomy: Tips, Tricks, cost minimisation, future robots |
Laparoscopic donor hepatectomy: the open procedure is no longer relevant |
Open donor hepatectomy cannot be ignored |
Is there a place for hybrid procedures? |
Impact of minimally invasive donor hepatectomy on biliary complications in recipients and donor |
Strategies for low remnant volume donors |
Coffee break |
Graft Inflow modulation: For |
Graft Inflow modulation: Against |
Complex Donor Anatomy |
Portal vein thrombosis and collaterals |
Minimally Invasive recipient surgery: Are we there? |
LUNCH |
Can we achieve zero mortality after LDLT? |
Vascular complications after LDLT |
Optimising outcomes in paediatric liver transplant |
Early Radiological interventions after LDLT |
TEA |
Early retransplant after LDLT |
Liver biopsy in the first 2 weeks after LDLT |
LDLT: current and future perspective |
HALL B (Hepatology) |
Topics |
Session 1: Immunosuppression in LT |
Immunosuppression in different clinical situations |
Role of biomarkers in rejection post LT |
Managing pregnancy in liver transplant recipient |
Session 2: Renal issues in LT |
Optimizing renal parameters and hyponatremia prior to transplant |
Early post operative management of a sick recipient |
Sequential versus combined liver kidney transplant-Is there a consensus? |
TEA |
Session 3: Infections in LT |
Antibiotics stewardship in LT -Less is more? |
When is infection a contraindication for transplantation? |
Fungal infections in post LT period -Risk factors and management |
LUNCH |
Session 4: Post LT Issues- I |
Post LT metabolic syndrome |
Management of diabetes in Pre and Post-transplant period |
Management of post LT HCC recurrence |
Session 5: Post LT Issues- II |
How does one differentiate between Rejection, SFSS, Sepsis in the early post Liver Transplant period |
Prevention of Post Transplant Hepatitis B reactivation: Evolution from HBIG to NA's to NA withdrawal |
Role of AI/Machine learning in LT |
TEA |
Session 6: Miscellaneous |
ATT Hepatotoxicity induced Liver failure: Characterization & Algorithmic approach to medical management |
Malignancy and liver transplant-Guidelines versus practical approach |
Management - Pre & Post Transplant |
New potential therapeutic drug targets |
Outcomes of hepatitis B virus positive grafts |
Management of chronic hepatitis C infection in children- An update |
HALL C |
Topics |
Pre Lunch Session: Transplant Coordinators Workshop |
Welcome address |
Definition and diagnosis of brain stem death |
Progress in Brain death donation in India |
Brain death donation- Hurdles and solutions |
DCD/Non heart beating donation- Potential and feasibility in India |
TEA |
Debate- Donor family should be given incentive- for/against |
Protocols to be followed in Brain death patients who are not donors |
How to promote deceased organ donation in private hospitals |
How to overcome the cultural barriers in in deceased organ donation |
Media and public awareness in organ donation |
Role of NGOs and religious bodies in deceased organ donation |
Role of government in promoting organ donation |
Ethical issues in organ allocation and patient selection |
Organ referral process- the trick for success |
Do’s and don’t of councelling for donation - the fine line |
Multiple listing in various centre- justification and problems faced |
Should the organ travel for recipient in Indian set up |
Responsibilities of procurement coordinator in pre, peri and post organ procurement |
Post Lunch Session |
Surgical Workshops- (Possibilities-Vascular anastomosis, Parenchymal transection devices, Ultrsound for surgeons, Robotic trainer/ 3 d printing technology/ VR training/ Machine perfusion) |
Anesthesia workshops-( Possibilities- TEE, TEG, TCD monitoring Regional blocks for donor anesthesia) |
Hepatology workshop-An approach to liver pathology |
General body meeting- hall A on Saturday OR Friday – one hour |
iLDLT Vanguard session: Saturday/Sunday Hall B |
HALL A |
Topics |
Liver Transplant in public Sector |
LT In Kazakhstan: impact of collaboration with other Centres |
LT in Iran: How we developed both DDLT and LDLT |
Panel Discussion: How to start a LDLT program? |
Government support for LT |
Improving gender imbalance in LDLT in India |
Managing patients transplanted abroad |
LDLT: Infrastructure First |
LDLT: Trained Team First |
TEA |
Patient Selection |
HCC beyond Milan: Where do we stand? |
LDLT for ACLF 3 |
Futility scores in LDLT |
Alcoholic Hepatitis: To transplant or not |
LUNCH |
LDLT for Hepatorenal Syndrome |
Medical contraindications to LDLT |
Video Session |
Multiple donor ducts |
The optimal biliary reconstruction |
Anterior sector drainage |
Multiple right hepatic veins (Inferior?) |
Multiple portal veins |
Monosegment graft |
Medially reduced graft |
Dissected recipient artery |
Atretic portal vein in BA |
Complete PVT and renoportal jump graft |
HALL B (Anesthesia) |
Topics |
Non heart beating donor- How to increase the donor pool |
Fibrinogen concentrate and prothrombin concentrate in LT : Is there any flip side? |
Citrate Anticoagulation for CRRT in CLD : Is it safe? |
Role of ECMO in Liver recipient |
Diastolic Dysfunction: A silent peril - Optimisation & Management |
Role of Parenteral Nutrition in patients with liver disease |
Assessment of fluid responsiveness- recent updates |
Case Discussion: Coronary revascularization before or after LDLT? Dilemma in dCLD patients with history of CAD |
Refractory vasoplegia- recent updates |
Metabolic Liver disease - Challenges - crisis prevention & management |
Massive Transfusion to cell save or not (Pro/ Con) |
Total Intravenous Anesthesia in LDLT |
Recipients with persisting encephalopathy: Pros and Cons of early tracheostomy after LT |
The optimal strategy for managing Rejection and Sepsis in the early postoperative transplant period |
PLEX in EGD – what is the evidence? |
Need of thromboprophylaxis in LDLT: Specific scenarios/indication |
HALL C |
Topics |
Panel Discussion- Ensuring Gender equality in career opportunities in Liver Transplantation- |
Interventional Radiology In cirrhosis |
TIPS: indications and late results |
Portal vein recanalization |
HVOT: Intervention vs Transplant |
LTSI Free paper sessions |
LTSI on the Pubmed |
HALL A |
Topics |
Session 1: ABOi LT |
Desensitization protocols |
Postoperative management |
Diffuse Ischemic Biliary strictures |
State of the Art Lecture: Donor and recipient genetic interaction – thinking beyond the MHC. |
Session 2: LT for ALF and ACLF |
Plasmapheresis for ALF: does it alter patient selection criteria |
ACLF definitions |
Reversibility in ACLF |
When to transplant in ALF |
Session 3: HCC |
Liver Resection for major vascular tumor invasion |
Current tools for predicting tumor behavior |
Downstaging protocols in HCC; |
TARE; indications and combinations with systemic therapy |
Evolving Strategies in LDLT for Hepatocellular Carcinoma |
Lunch |
Session 4 |
Panel discussion |
Developing LT in the public sector- do we really need Pvt hospitals to help? |
Ensuring donor safety during the MIS learning curve |
Debate |
Hub and Spoke Model - Is it the right fit for transplant outside metros? |
Session 5: Cadaveric Transplant |
How can we improve deceased donor management in India? |
Gender imbalance in LDLT in India- Is it real? can we correct it? (patients) – Gomathy Narasimhan |
Machine perfusion; How far are we from routine use |
Hypothermic Machine Perfusion vs NMP- which strategy works best for India |
NOTTO - how far have we come |
HALL B (Course: Pediatric Hepatology) |
Topics |
Timing of liver transplant in children with portal hypertension and mild liver dysfunction |
A second chance for “Too sick for transplant” – Is it possible? |
Role of creatinine, sarcopenia, and hyponatremia in the listing- Does PELD need modifications? |
Metabolic liver disease- When to and when not to transplant? |
Discussion |
Session 2: Pediatric liver transplant- Specific concerns |
Strategies to prevent portal vein thrombosis |
Graft volume and outcome |
On table extubation- Pros and Cons |
Liver transplant for non-hepatoblastoma tumors |
Domino liver transplant- Techniques and outcome |
Discussion |
Session 3: Post-transplant care |
Induction immunosuppression therapy- Is it worth it? |
Early diagnosis and management of biliary complications |
Recurrence of pediatric liver diseases after LT |
Monitoring of CMV and EBV post-transplant |
Discussion |
Session 4: Long-term outcome |
Graft fibrosis and long-term survival |
Operational tolerance after transplant- A pipe dream |
Post-transplant vaccination- Live and Killed |
Post-transplant PTLD and other malignancies |
Discussion |
THEME : LIVER TRANSPLANT BEYOND BORDERS
Day 1 - 17 November, Friday
Day 2 - 18 November, Saturday
Day 3 - 19 November, Sunday
HALL A |
Topics |
Robotic donor hepatectomy: Tips, Tricks, cost minimisation, future robots |
Laparoscopic donor hepatectomy: the open procedure is no longer relevant |
Open donor hepatectomy cannot be ignored |
Is there a place for hybrid procedures? |
Impact of minimally invasive donor hepatectomy on biliary complications in recipients and donor |
Strategies for low remnant volume donors |
Coffee break |
Graft Inflow modulation: For |
Graft Inflow modulation: Against |
Complex Donor Anatomy |
Portal vein thrombosis and collaterals |
Minimally Invasive recipient surgery: Are we there? |
LUNCH |
Can we achieve zero mortality after LDLT? |
Vascular complications after LDLT |
Optimising outcomes in paediatric liver transplant |
Early Radiological interventions after LDLT |
TEA |
Early retransplant after LDLT |
Liver biopsy in the first 2 weeks after LDLT |
LDLT: current and future perspective |
HALL B (Hepatology) |
Topics |
Session 1: Immunosuppression in LT |
Immunosuppression in different clinical situations |
Role of biomarkers in rejection post LT |
Managing pregnancy in liver transplant recipient |
Session 2: Renal issues in LT |
Optimizing renal parameters and hyponatremia prior to transplant |
Early post operative management of a sick recipient |
Sequential versus combined liver kidney transplant-Is there a consensus? |
TEA |
Session 3: Infections in LT |
Antibiotics stewardship in LT -Less is more? |
When is infection a contraindication for transplantation? |
Fungal infections in post LT period -Risk factors and management |
LUNCH |
Session 4: Post LT Issues- I |
Post LT metabolic syndrome |
Management of diabetes in Pre and Post-transplant period |
Management of post LT HCC recurrence |
Session 5: Post LT Issues- II |
How does one differentiate between Rejection, SFSS, Sepsis in the early post Liver Transplant period |
Prevention of Post Transplant Hepatitis B reactivation: Evolution from HBIG to NA's to NA withdrawal |
Role of AI/Machine learning in LT |
TEA |
Session 6: Miscellaneous |
ATT Hepatotoxicity induced Liver failure: Characterization & Algorithmic approach to medical management |
Malignancy and liver transplant-Guidelines versus practical approach |
Management - Pre & Post Transplant |
New potential therapeutic drug targets |
Outcomes of hepatitis B virus positive grafts |
Management of chronic hepatitis C infection in children- An update |
HALL C |
Topics |
Pre Lunch Session: Transplant Coordinators Workshop |
Welcome address |
Definition and diagnosis of brain stem death |
Progress in Brain death donation in India |
Brain death donation- Hurdles and solutions |
DCD/Non heart beating donation- Potential and feasibility in India |
TEA |
Debate- Donor family should be given incentive- for/against |
Protocols to be followed in Brain death patients who are not donors |
How to promote deceased organ donation in private hospitals |
How to overcome the cultural barriers in in deceased organ donation |
Media and public awareness in organ donation |
Role of NGOs and religious bodies in deceased organ donation |
Role of government in promoting organ donation |
Ethical issues in organ allocation and patient selection |
Organ referral process- the trick for success |
Do’s and don’t of councelling for donation - the fine line |
Multiple listing in various centre- justification and problems faced |
Should the organ travel for recipient in Indian set up |
Responsibilities of procurement coordinator in pre, peri and post organ procurement |
Post Lunch Session |
Surgical Workshops- (Possibilities-Vascular anastomosis, Parenchymal transection devices, Ultrsound for surgeons, Robotic trainer/ 3 d printing technology/ VR training/ Machine perfusion) |
Anesthesia workshops-( Possibilities- TEE, TEG, TCD monitoring Regional blocks for donor anesthesia) |
Hepatology workshop-An approach to liver pathology |
General body meeting- hall A on Saturday OR Friday – one hour |
iLDLT Vanguard session: Saturday/Sunday Hall B |
HALL A |
Topics |
Liver Transplant in public Sector |
LT In Kazakhstan: impact of collaboration with other Centres |
LT in Iran: How we developed both DDLT and LDLT |
Panel Discussion: How to start a LDLT program? |
Government support for LT |
Improving gender imbalance in LDLT in India |
Managing patients transplanted abroad |
LDLT: Infrastructure First |
LDLT: Trained Team First |
TEA |
Patient Selection |
HCC beyond Milan: Where do we stand? |
LDLT for ACLF 3 |
Futility scores in LDLT |
Alcoholic Hepatitis: To transplant or not |
LUNCH |
LDLT for Hepatorenal Syndrome |
Medical contraindications to LDLT |
Video Session |
Multiple donor ducts |
The optimal biliary reconstruction |
Anterior sector drainage |
Multiple right hepatic veins (Inferior?) |
Multiple portal veins |
Monosegment graft |
Medially reduced graft |
Dissected recipient artery |
Atretic portal vein in BA |
Complete PVT and renoportal jump graft |
HALL B (Anesthesia) |
Topics |
Non heart beating donor- How to increase the donor pool |
Fibrinogen concentrate and prothrombin concentrate in LT : Is there any flip side? |
Citrate Anticoagulation for CRRT in CLD : Is it safe? |
Role of ECMO in Liver recipient |
Diastolic Dysfunction: A silent peril - Optimisation & Management |
Role of Parenteral Nutrition in patients with liver disease |
Assessment of fluid responsiveness- recent updates |
Case Discussion: Coronary revascularization before or after LDLT? Dilemma in dCLD patients with history of CAD |
Refractory vasoplegia- recent updates |
Metabolic Liver disease - Challenges - crisis prevention & management |
Massive Transfusion to cell save or not (Pro/ Con) |
Total Intravenous Anesthesia in LDLT |
Recipients with persisting encephalopathy: Pros and Cons of early tracheostomy after LT |
The optimal strategy for managing Rejection and Sepsis in the early postoperative transplant period |
PLEX in EGD – what is the evidence? |
Need of thromboprophylaxis in LDLT: Specific scenarios/indication |
HALL C |
Topics |
Panel Discussion- Ensuring Gender equality in career opportunities in Liver Transplantation- |
Interventional Radiology In cirrhosis |
TIPS: indications and late results |
Portal vein recanalization |
HVOT: Intervention vs Transplant |
LTSI Free paper sessions |
LTSI on the Pubmed |
HALL A |
Topics |
Session 1: ABOi LT |
Desensitization protocols |
Postoperative management |
Diffuse Ischemic Biliary strictures |
State of the Art Lecture: Donor and recipient genetic interaction – thinking beyond the MHC. |
Session 2: LT for ALF and ACLF |
Plasmapheresis for ALF: does it alter patient selection criteria |
ACLF definitions |
Reversibility in ACLF |
When to transplant in ALF |
Session 3: HCC |
Liver Resection for major vascular tumor invasion |
Current tools for predicting tumor behavior |
Downstaging protocols in HCC; |
TARE; indications and combinations with systemic therapy |
Evolving Strategies in LDLT for Hepatocellular Carcinoma |
Lunch |
Session 4 |
Panel discussion |
Developing LT in the public sector- do we really need Pvt hospitals to help? |
Ensuring donor safety during the MIS learning curve |
Debate |
Hub and Spoke Model - Is it the right fit for transplant outside metros? |
Session 5: Cadaveric Transplant |
How can we improve deceased donor management in India? |
Gender imbalance in LDLT in India- Is it real? can we correct it? (patients) – Gomathy Narasimhan |
Machine perfusion; How far are we from routine use |
Hypothermic Machine Perfusion vs NMP- which strategy works best for India |
NOTTO - how far have we come |
HALL B (Course: Pediatric Hepatology) |
Topics |
Timing of liver transplant in children with portal hypertension and mild liver dysfunction |
A second chance for “Too sick for transplant” – Is it possible? |
Role of creatinine, sarcopenia, and hyponatremia in the listing- Does PELD need modifications? |
Metabolic liver disease- When to and when not to transplant? |
Discussion |
Session 2: Pediatric liver transplant- Specific concerns |
Strategies to prevent portal vein thrombosis |
Graft volume and outcome |
On table extubation- Pros and Cons |
Liver transplant for non-hepatoblastoma tumors |
Domino liver transplant- Techniques and outcome |
Discussion |
Session 3: Post-transplant care |
Induction immunosuppression therapy- Is it worth it? |
Early diagnosis and management of biliary complications |
Recurrence of pediatric liver diseases after LT |
Monitoring of CMV and EBV post-transplant |
Discussion |
Session 4: Long-term outcome |
Graft fibrosis and long-term survival |
Operational tolerance after transplant- A pipe dream |
Post-transplant vaccination- Live and Killed |
Post-transplant PTLD and other malignancies |
Discussion |